EMEA-001439-PIP01-13-M03 - paediatric investigation plan
Dasabuvir (sodium monohydrate)
PIPHuman
AbbVie Ltd
AbbVie Ltd
E-mail: paediatricsteam@abbvie.com
Tel: +44 7341101902
P/0289/2020 : EMA decision of 12 August 2020 on the acceptance of a modification of an agreed paediatric investigation plan for dasabuvir (sodium monohydrate) (Exviera) (EMEA-001439-PIP01-13-M03)